EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Influence of Glutamate Neurotransmission Genes on the Outcomes of Antipsychotic Treatments

Marc Cendrós, Rosa Catalán iD, Mercè Torra, Rafael Penadés, Alexandre González-Rodríguez, Mercè Brunet, Josefina Perez-Blanco, Natalia Cullell, Alexandre Serra-Llovich, Marta H Hernandez, María J Arranz iD

Pharmacopsychiatry · 01.09.2025 · 58 (05) · 205-215

DOI: 10.1055/a-2603-0871 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacopsychiatry, erschienen am 01.09.2025. Verfasst von Marc Cendrós und 10 weiteren Autor:innen. Beteiligte Einrichtung: Eugenomic S.L., Barcelona, Spain. Hauptthemen laut MEDLINE: Antipsychotic Agents, Schizophrenia, Synaptic Transmission, Glutamic Acid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Traditionally, the aetiology of schizophrenia has been attributed to dopaminergic neurotransmission, but more recent information points to the role of glutamate pathways. Glutamatergic involvement in schizophrenia might be extensible to drug response. The aim of the study was to explore whether the variation in glutamate receptors, transporters and metabolism can influence the outcome of drug treatments. A total of 45 polymorphisms in the genes GRIN1, GRIN2A, GRIN2B, GRIN3A, GRIA1, GRIK2, GRM2, GRM3, GRM5, GRM8, SLC1A1, SLC1A3 and GAD1 were genotyped in 258 patients with schizophrenia. Efficacy and side effects were evaluated with the Positive and Negative Symptoms Scale and the UKU scale, respectively, at baseline and after 12 weeks. The analysis revealed associations between outcomes, including response and adverse effects and genetic variants in several genes (GAD1, GRIA1, GRIN2A, GRIN3A, GRIK2, GRM2, GRM5, GRM8 and SLC1A3). An association of rs1864205 in GRIA1 with autonomic side effects bordered statistical significance after correction for multiple comparisons. Our results suggest that genetic variation in glutamatergic pathways can influence the efficacy and safety of antipsychotic drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antipsychotic AgentsSchizophreniaSynaptic TransmissionGlutamic AcidReceptors, GlutamateHumansMaleFemaleAdultMiddle AgedTreatment OutcomePolymorphism, Single NucleotideGenotypeYoung Adult

Substanzen

Antipsychotic AgentsGlutamic AcidReceptors, Glutamate

Autor:innen und Institutionen

  • Eugenomic S.L., Barcelona, Spain.
  • Fundació Docència i Recerca Mútua Terrassa Terrassa, Spain.
  • Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Institut de Recerca Biomèdica Sant Pau (IIB-Sant Pau), Barcelona, Spain.
  • Barcelona Clinic Schizophrenia Unit (BCSU), Neurosciences Institute, Hospital Clínic of Barcelona, University of Barcelona, IDIBAPS, Barcelona, Spain.
  • Pharmacology & Toxicology Unit, Dept. Biochemistry & Molecular Genetics, Hospital Clínic of Barcelona, Barcelona, Spain.
  • Dept. Mental Health, Mutua Terrassa University Hospital, Fundació Docència i Recerca Mutua Terrassa, University of Barcelona, CIBERSAM, Barcelona, Terrassa, Spain.

ORCID-Profile: Rosa Catalán, María J Arranz

Zitieren

APA

Cendrós, M., Catalán, R., Torra, M., Penadés, R., González-Rodríguez, A., Brunet, M., Perez-Blanco, J., Cullell, N., Serra-Llovich, A., Hernandez, M. H., & Arranz, M. J. (2025). Influence of Glutamate Neurotransmission Genes on the Outcomes of Antipsychotic Treatments. Pharmacopsychiatry, 58(05), 205-215. https://doi.org/10.1055/a-2603-0871

Vancouver

Cendrós M, Catalán R, Torra M, Penadés R, González-Rodríguez A, Brunet M, et al. Influence of Glutamate Neurotransmission Genes on the Outcomes of Antipsychotic Treatments. Pharmacopsychiatry. 2025;58(05):205-215. doi:10.1055/a-2603-0871

BibTeX
@article{Cendrs2025,
  author = {Cendrós, Marc and Catalán, Rosa and Torra, Mercè and Penadés, Rafael and González-Rodríguez, Alexandre and Brunet, Mercè and Perez-Blanco, Josefina and Cullell, Natalia and Serra-Llovich, Alexandre and Hernandez, Marta H and Arranz, María J},
  title = {Influence of Glutamate Neurotransmission Genes on the Outcomes of Antipsychotic Treatments},
  journal = {Pharmacopsychiatry},
  year = {2025},
  volume = {58},
  number = {05},
  pages = {205--215},
  doi = {10.1055/a-2603-0871}
}
Kostenlos starten →